Host: |
Rabbit |
Applications: |
WB/IHC |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-RNF166 (102-201) is suitable for use in Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IHC-P 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
RNF166 |
Gene ID: |
115992 |
Uniprot ID: |
RN166_HUMAN |
Immunogen Region: |
102-201 |
Immunogen: |
A synthetic peptide corresponding to a sequence within amino acids 102-201 of human RNF166 (NP_849163.1). |
Immunogen Sequence: |
NKKVTLAKMRVHISSCLKVQ EQMANCPKFVPVVPTSQPIP SNIPNRSTFACPYCGARNLD QQELVKHCVESHRSDPNRVV CPICSAMPWGDPSYKSANFL |
Function | E3 ubiquitin-protein ligase that promotes the ubiquitination of different substrates. In turn, participates in different biological processes including interferon production or autophagy. Plays a role in the activation of RNA virus-induced interferon-beta production by promoting the ubiquitination of TRAF3 and TRAF6. Also plays a role in the early recruitment of autophagy adapters to bacteria. Mediates 'Lys-29' and 'Lys-33'-linked ubiquitination of SQSTM1 leading to xenophagic targeting of bacteria and inhibition of their replication. |
Protein Name | E3 Ubiquitin-Protein Ligase Rnf166Ring Finger Protein 166Ring-Type E3 Ubiquitin Transferase Rnf166 |
Cellular Localisation | Cytoplasm |
Alternative Antibody Names | Anti-E3 Ubiquitin-Protein Ligase Rnf166 antibodyAnti-Ring Finger Protein 166 antibodyAnti-Ring-Type E3 Ubiquitin Transferase Rnf166 antibodyAnti-RNF166 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance